Today, shares of Repros Therapeutics (NASDAQ:RPRX) have crossed bearishly below their 10-day moving average of $9.31 on a volume of 135K shares. Swing traders may find an opportunity for a short position, as such a crossover often suggests lower prices in the near term.
Repros Therapeutics Inc. is a clinical stage biopharmaceutical company. The Company develops new drugs to treat hormonal and reproductive system disorders.
In the past 52 weeks, Repros Therapeutics share prices have been bracketed by a low of $3.34 and a high of $19.12 and are now at $9.16, 174% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has declined 3.5%.
Repros Therapeutics (NASDAQ:RPRX) has potential upside of 123.8% based on a current price of $9.16 and analysts' consensus price target of $20.50. The stock should find initial resistance at its 50-day moving average (MA) of $12.23 and further resistance at its 200-day MA of $12.36.